v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (9,593,000) $ (8,927,520)
Adjustments to reconcile net loss to net cash used in operating activities:    
Fair value of common stock issued in exchange for services 406,500
Share-based compensation 1,976,351 650,921
Amortization 40,012 39,371
Decrease in assets    
Prepaid expenses (24,000) (31,678)
Increase in liabilities    
Accounts payable and accrued expenses 1,452,651 890,903
Accounts payable and accrued expenses - related parties 2,558 4,460
Net cash used in operating activities (6,145,428) (6,967,043)
CASH FLOWS FROM INVESTING ACTIVITIES    
Investment in patents (12,378) (1,118)
Net cash used in investing activities (12,378) (1,118)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from sale of 10% secured convertible notes payable - stockholders 3,305,000
Proceeds from sale of Series B Preferred Stock 3,723,020
Net cash provided by financing activities 3,305,000 3,723,020
DECREASE IN CASH AND CASH EQUIVALENTS (2,852,806) (3,245,141)
CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR 3,011,493 6,256,634
CASH AND CASH EQUIVALENTS - END OF YEAR 158,687 3,011,493
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:    
Interest
Income taxes
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES:    
Accrued preferred dividends 2,827,072 2,705,635
Conversion of 10% secured convertible note payable and accrued interest into 3,383 and 5,399 shares of Series B Preferred Stock $ 304,468 $ 485,894